Jinling Pharmaceutical Company Company Description

Jinling Pharmaceutical Company Limited, together with its subsidiaries, manufactures and sells pharmaceuticals and medical devices in China and internationally.

It offers Mailuoning injection and oral solution for the treatment of thromboangiitis and arteriosclerosis obliterans, as well as cerebral and venous thrombosis; Sulifei, a ferrous succinate tablet for the prevention and treatment of iron deficiency anemia; Lentinan injection, an adjuvant therapy for the treatment of malignant tumors; and absorbable gelatin sponges for the treatment of wound bleeding and trauma hemostasis.

The company also provides traditional Chinese medicines, chemical medicines, active pharmaceutical ingredients, and pharmaceutical intermediates.

In addition, it engages in elderly care services, rehabilitation therapy, psychological counseling, and end-of-life care; hospital management; technical services; and healthcare investment activities.

The company was incorporated in 1998 and is headquartered in Nanjing, China.

Jinling Pharmaceutical Company Limited

Country	China
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	5,789
CEO	Hai Chen

Contact Details

Address: Jinling Pharmaceutical Building Nanjing, 210009 China
Phone	86 25 8311 8511
Website	jlyy1999.com

Stock Details

Ticker Symbol	000919
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE0000010W5
SIC Code	2834

Key Executives

Name	Position
Hai Chen	President and Director
Yang Wang	Vice President, Chief Accountant, Secretary and Non-Independent Director
Quan Li	Chief Economist
Mingyi Jia	Chief Engineer
Jian Wang	Executive Vice President and Non-Independent Director
Jian Li	Vice President
Xinning Zhu	Assistant to President
Zhenxin Xi	General Manager Assistant
Xin Liu	Assistant to the President
Yuan Xin Fan	Assistant to the President